Sort
21,453 grants matching “tuberculosis”
Population Based Molecular Epidemiology of TB
$1,162,560University Of California San Francisco · R01 · FY2004 · AI
Biocontainment Suite Renovation to Enhance Research
$1,162,443Univ Of Massachusetts Med Sch Worcester · C06 · FY2005 · RR
Oral BCG: Optimizing mucosal vaccination against tuberculosis
$1,162,224Philana Ling Lin · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI
PS05-003 TUBERCULOSIS CONTROL PROGRAM AND AIDS
$1,162,145Shea S Rabley · South Carolina Department Of Public Health · U52 · FY2007 · PS
Production of Pedigreed SPF Rhesus Macaques
$1,162,130Jeffrey A Roberts · University Of California At Davis · U42 · FY2021 · OD
A STINGing vaccine for TB
$1,161,477William Ramses Bishai · Johns Hopkins University · R01 · FY2023 · AI
Development and Support of the Pathway Tools Software
$1,161,153Peter D Karp · Sri International · R01 · FY2023 · AI
Development and Support of the Pathway Tools Software
$1,161,153Peter D Karp · Sri International · R01 · FY2024 · AI
Sample Processing Cartridges for Rapid PCR TB Detection
$1,160,774David Alland · Cepheid · R42 · FY2008 · AI
NATURAL HISTORY OF HIV INFECTION IN INJECTION DRUG USERS
$1,160,398Johns Hopkins University · R37 · FY2000 · DA
CAPRISA Clinical Trials Unit for AIDS/Tuberculosis Prevention and Treatment
$1,160,092Quarraisha Abdool Karim · Centre/Aids Programme/Res/South Africa · UM1 · FY2015 · AI
Addressing COVID-19 Testing Disparities in Vulnerable Populations Using a Community JITAI (Just in Time Adaptive Intervention) Approach - Phase II
$1,158,954David D McPherson · University Of Texas Hlth Sci Ctr Houston · UL1 · FY2022 · TR
Tuberculosis Surveillance, Prevention and Control, and Laboratory Upgrade
$1,158,894Maureen E Murphy · Ohio State Department Of Health · U52 · FY2012 · PS
Optimization and Advanced Proof-of-Concept Studies of a Listeria-vectored Multi-Antigenic Vaccine against Tuberculosis
$1,158,564Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2020 · AI
DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial
$1,157,460Payam Nahid · University Of California, San Francisco · U01 · FY2025 · AI
New targets against tuberculosis
$1,156,431Deborah T Hung · Broad Institute, Inc. · R01 · FY2018 · AI
A dual function TB subunit vaccine designed for non-interference with BCG and post-exposure activity
$1,155,591Rasmus Skaarup Mortensen · Statens Serum Institute · R01 · FY2021 · AI
Stellenbosch University Clinical Trials Unit (SUN-CTU)
$1,155,500Mark Fredric Cotton · Stellenbosch University · UM1 · FY2015 · AI
DEVELOPMENT OF A RECOMBINANT LISTERIA MONOCYTOGENES BOOSTER VACCINE AGAINST TUBERCULOSIS
$1,155,000University Of California, Los Angeles · · FY2012 · Department of Defense
TB Surrogate Markers for Assessing Reponse to Treatment (TB SMART Study)
$1,154,896Payam Nahid · University Of California, San Francisco · R01 · FY2015 · AI
ALABAMA/ZAMBIA HIV VACCINE CLINICAL TRIALS UNIT (HVTU)
$1,154,810University Of Alabama At Birmingham · U01 · FY2000 · AI
Durban International Clinical Trials Unit
$1,154,244Umesh G Lalloo · University Of Kwazulu-Natal · UM1 · FY2012 · AI
International Research in Korea: Clinical Studies of Drug-Resistant Tuberculosis
$1,153,780Clifton Barry · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Production of Pedigreed SPF Rhesus Macaques
$1,153,561Jeffrey A Roberts · University Of California At Davis · U42 · FY2022 · OD
Optimization and preclinical development of a TB Multiple Antigen Presenting System (MAPS) vaccine
$1,153,542Richard Malley · Boston Children'S Hospital · R01 · FY2021 · AI